Gene	O
transcription	O
through	O
activation	O
of	O
G-protein-coupled	B-protein
chemoattractant	I-protein
receptors	I-protein
.	O

Receptors	O
for	O
leukocyte	B-protein
chemoattractants	I-protein
,	O
including	O
chemokines	B-protein
,	O
are	O
traditionally	O
considered	O
to	O
be	O
responsible	O
for	O
the	O
activation	O
of	O
special	O
leukocyte	O
functions	O
such	O
as	O
chemotaxis	O
,	O
degranulation	O
,	O
and	O
the	O
release	O
of	O
superoxide	O
anions	O
.	O

Recently	O
,	O
these	O
G-protein-coupled	B-protein
serpentine	I-protein
receptors	I-protein
have	O
been	O
found	O
to	O
transduce	O
signals	O
leading	O
to	O
gene	O
transcription	O
and	O
translation	O
in	O
leukocytes	B-cell_type
.	O

Transcription	B-protein
factors	I-protein
,	O
such	O
as	O
NF	B-protein
kappa	I-protein
B	I-protein
and	O
AP-1	B-protein
,	O
are	O
activated	O
upon	O
stimulation	O
of	O
the	O
cells	O
with	O
several	O
chemoattractants	O
at	O
physiologically	O
relevant	O
concentrations	O
.	O

Activation	O
of	O
transcription	O
factors	O
through	O
these	O
receptors	O
involves	O
G-protein	B-protein
coupling	O
and	O
the	O
activation	O
of	O
protein	B-protein
kinases	I-protein
.	O

The	O
underlying	O
signaling	O
pathways	O
appear	O
to	O
be	O
different	O
from	O
those	O
utilized	O
by	O
TNF-alpha	B-protein
,	O
a	O
better	O
characterized	O
cytokine	O
that	O
induces	O
the	O
transcription	O
of	O
immediate-early	B-DNA
genes	I-DNA
.	O

Chemoattractants	O
stimulate	O
the	O
expression	O
of	O
several	O
inflammatory	B-protein
cytokines	I-protein
and	O
chemokines	B-protein
,	O
which	O
in	O
turn	O
may	O
activate	O
their	O
respective	O
receptors	O
and	O
initiate	O
an	O
autocrine	O
regulatory	O
mechanism	O
for	O
persistent	O
cytokine	B-protein
and	O
chemokine	B-protein
gene	O
expression	O
.	O

Gene	NULL
Expression	NULL
,	NULL
Vol	NULL
.	NULL

5	NULL
,	NULL
pp	NULL
.	NULL

205-215	NULL
,	NULL
1996	NULL
1052-2166/96	NULL
$	NULL
5.00	NULL
+	NULL
.00	NULL
Printed	NULL
in	NULL
the	NULL
USA	NULL
.	NULL

All	NULL
rights	NULL
reserved	NULL
.	NULL

Copyright	NULL
©	NULL
1996	NULL
Cognizant	NULL
Comm	NULL
.	NULL

Corp.	NULL
Gene	NULL
Transcription	NULL
Through	NULL
Activation	NULL
of	NULL
G-Protein-Coupled	NULL
Chemoattractant	NULL
Receptors	NULL
RICHARD	NULL
D.	NULL
YE	NULL
,	NULL
'	NULL
ZHIXING	NULL
PAN	NULL
,	NULL
VLADIMIR	NULL
V.	NULL
KRAVCHENKO	NULL
,	NULL
DARREN	NULL
D.	NULL
BROWNING	NULL
,	NULL
AND	NULL
ERIC	NULL
R.	NULL
PROSSNITZ	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
10666	NULL
N.	NULL
Torrey	NULL
Pines	NULL
Road	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92037	NULL
Receptors	NULL
for	NULL
leukocyte	NULL
chemoattractants	NULL
,	NULL
including	NULL
chemokines	NULL
,	NULL
are	NULL
traditionally	NULL
considered	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
special	NULL
leukocyte	NULL
functions	NULL
such	NULL
as	NULL
chemotaxis	NULL
,	NULL
degranulation	NULL
,	NULL
and	NULL
the	NULL
release	NULL
of	NULL
superoxide	NULL
anions	NULL
.	NULL

Recently	NULL
,	NULL
these	NULL
G-protein-coupled	NULL
serpentine	NULL
receptors	NULL
have	NULL
been	NULL
found	NULL
to	NULL
transduce	NULL
signals	NULL
leading	NULL
to	NULL
gene	NULL
transcription	NULL
and	NULL
translation	NULL
in	NULL
leukocytes	NULL
.	NULL

Transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
NF	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
,	NULL
are	NULL
activated	NULL
upon	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
several	NULL
chemoattractants	NULL
at	NULL
physiologi-cally	NULL
relevant	NULL
concentrations	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
factors	NULL
through	NULL
these	NULL
receptors	NULL
involves	NULL
G-protein	NULL
coupling	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
protein	NULL
kinases	NULL
.	NULL

The	NULL
underlying	NULL
signaling	NULL
pathways	NULL
appear	NULL
to	NULL
be	NULL
different	NULL
from	NULL
those	NULL
utilized	NULL
by	NULL
TNF-a	NULL
,	NULL
a	NULL
better	NULL
characterized	NULL
cytokine	NULL
that	NULL
induces	NULL
the	NULL
transcription	NULL
of	NULL
immediate-early	NULL
genes	NULL
.	NULL

Chemoattractants	NULL
stimulate	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
inflammatory	NULL
cytokines	NULL
and	NULL
chemokines	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
may	NULL
activate	NULL
their	NULL
respective	NULL
receptors	NULL
and	NULL
initiate	NULL
an	NULL
autocrine	NULL
regulatory	NULL
mechanism	NULL
for	NULL
persistent	NULL
cytokine	NULL
and	NULL
chemokine	NULL
gene	NULL
expression	NULL
.	NULL

Transcription	NULL
activation	NULL
NFkB	NULL
AP-1	NULL
Chemoattractant	NULL
Receptors	NULL
G-protein	NULL
LEUKOCYTE	NULL
infiltration	NULL
is	NULL
characteristic	NULL
of	NULL
in-	NULL
cells	NULL
.	NULL

Chemokines	NULL
have	NULL
longer	NULL
lives	NULL
and	NULL
higher	NULL
flammatory	NULL
reaction	NULL
to	NULL
tissue	NULL
injuries	NULL
caused	NULL
by	NULL
specificity	NULL
for	NULL
leukocyte	NULL
subtypes	NULL
.	NULL

They	NULL
can	NULL
be	NULL
trauma	NULL
,	NULL
invasion	NULL
of	NULL
foreign	NULL
particles	NULL
,	NULL
ischemia-	NULL
further	NULL
divided	NULL
into	NULL
the	NULL
CXC	NULL
(	NULL
«	NULL
)	NULL
and	NULL
CC	NULL
(	NULL
@	NULL
)	NULL
reperfusion	NULL
,	NULL
cancer	NULL
,	NULL
autoimmune	NULL
diseases	NULL
,	NULL
and	NULL
classes	NULL
depending	NULL
on	NULL
the	NULL
location	NULL
of	NULL
the	NULL
first	NULL
two	NULL
other	NULL
conditions	NULL
.	NULL

This	NULL
process	NULL
begins	NULL
with	NULL
activa-	NULL
of	NULL
the	NULL
four	NULL
cysteines	NULL
in	NULL
the	NULL
molecules	NULL
(	NULL
3,22	NULL
)	NULL
.	NULL

tion	NULL
of	NULL
leukocytes	NULL
by	NULL
a	NULL
collection	NULL
of	NULL
cell-attracting	NULL
Chemoattractants	NULL
are	NULL
pleiotropic	NULL
activators	NULL
of	NULL
chemicals	NULL
termed	NULL
chemoattractants	NULL
.	NULL

Two	NULL
classes	NULL
leukocyte	NULL
functions	NULL
.	NULL

At	NULL
subnanomolar	NULL
concentra-of	NULL
chemoattractants	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

The	NULL
tions	NULL
,	NULL
chemoattractants	NULL
induce	NULL
directed	NULL
migration	NULL
classical	NULL
chemoattractants	NULL
consist	NULL
of	NULL
the	NULL
bacteri-	NULL
of	NULL
leukocytes	NULL
along	NULL
a	NULL
chemical	NULL
concentration	NULL
gra-ally	NULL
derived	NULL
N-formyl	NULL
peptide	NULL
fMet-Leu-Phe	NULL
dient	NULL
(	NULL
chemotaxis	NULL
)	NULL
.	NULL

Chemoattractants	NULL
such	NULL
as	NULL
(	NULL
FMLP	NULL
)	NULL
,	NULL
the	NULL
activated	NULL
complement	NULL
component	NULL
FMLP	NULL
also	NULL
cause	NULL
shedding	NULL
of	NULL
L-selectin	NULL
and	NULL
acti-CSa	NULL
,	NULL
the	NULL
lipid	NULL
mediator	NULL
platelet-activating	NULL
factor	NULL
vation	NULL
of	NULL
integrins	NULL
.	NULL

At	NULL
higher	NULL
concentrations	NULL
(	NULL
10-	NULL
(	NULL
PAF	NULL
)	NULL
,	NULL
and	NULL
the	NULL
arachidonic	NULL
acid	NULL
product	NULL
leuko-	NULL
100	NULL
nM	NULL
)	NULL
,	NULL
chemoattractants	NULL
stimulate	NULL
phagocyte	NULL
triene	NULL
B	NULL
,	NULL
(	NULL
LTB	NULL
,	NULL
)	NULL
(	NULL
30	NULL
)	NULL
.	NULL

These	NULL
chemoattractants	NULL
are	NULL
degranulation	NULL
and	NULL
the	NULL
generation	NULL
of	NULL
superoxide	NULL
well	NULL
characterized	NULL
and	NULL
are	NULL
generally	NULL
short-lived	NULL
at	NULL
anions	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Attention	NULL
has	NULL
been	NULL
drawn	NULL
recently	NULL
to	NULL
sites	NULL
of	NULL
inflammation	NULL
.	NULL

The	NULL
more	NULL
recently	NULL
discov-	NULL
an	NULL
additional	NULL
function	NULL
of	NULL
chemoattractants	NULL
:	NULL
in-ered	NULL
chemotactic	NULL
cytokines	NULL
(	NULL
chemokines	NULL
)	NULL
consist	NULL
duction	NULL
of	NULL
the	NULL
synthesis	NULL
and	NULL
secretion	NULL
of	NULL
proin-of	NULL
a	NULL
group	NULL
of	NULL
8-10-kDa	NULL
polypeptides	NULL
secreted	NULL
by	NULL
flammatory	NULL
cytokines	NULL
,	NULL
including	NULL
chemokines	NULL
.	NULL

Be-leukocytes	NULL
,	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
certain	NULL
tumor	NULL
cause	NULL
chemoattractants	NULL
are	NULL
one	NULL
of	NULL
the	NULL
first	NULL
factors	NULL
Received	NULL
December	NULL
4	NULL
,	NULL
1995	NULL
;	NULL
revision	NULL
accepted	NULL
January	NULL
11	NULL
,	NULL
1996	NULL
.	NULL

'Address	NULL
correspondence	NULL
to	NULL
Richard	NULL
D.	NULL
Ye	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Ph.D.	NULL
205	NULL
206	NULL
that	NULL
leukocytes	NULL
encounter	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
(	NULL
31	NULL
)	NULL
,	NULL
their	NULL
ability	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
may	NULL
be	NULL
significant	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
recruitment	NULL
of	NULL
additional	NULL
leukocytes	NULL
and	NULL
the	NULL
modulation	NULL
of	NULL
a	NULL
local	NULL
cytokine	NULL
network	NULL
.	NULL

Monocytes	NULL
and	NULL
neutrophils	NULL
are	NULL
major	NULL
sources	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
including	NULL
chemokines	NULL
.	NULL

Here	NULL
we	NULL
present	NULL
results	NULL
from	NULL
our	NULL
current	NULL
study	NULL
of	NULL
the	NULL
mechanisms	NULL
for	NULL
chemoattractant	NULL
re-ceptor-mediated	NULL
gene	NULL
transcription	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
chemoattractant	NULL
binding	NULL
to	NULL
these	NULL
receptors	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
NFB	NULL
and	NULL
AP-1	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
transcription	NULL
activators	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
immediate-early	NULL
genes	NULL
.	NULL

The	NULL
activation	NULL
process	NULL
requires	NULL
functional	NULL
coupling	NULL
to	NULL
G-proteins	NULL
and	NULL
appears	NULL
to	NULL
utilize	NULL
signaling	NULL
pathways	NULL
different	NULL
from	NULL
those	NULL
employed	NULL
by	NULL
several	NULL
other	NULL
inducers	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
such	NULL
as	NULL
TNF-	NULL
«	NULL
and	NULL
PMA	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
transcription	NULL
leading	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
cytokines	NULL
and	NULL
chemokines	NULL
might	NULL
reflect	NULL
a	NULL
fundamental	NULL
role	NULL
of	NULL
chemoattractants	NULL
.	NULL

A	NULL
more	NULL
detailed	NULL
understanding	NULL
of	NULL
the	NULL
signaling	NULL
mechanisms	NULL
involved	NULL
will	NULL
likely	NULL
reveal	NULL
valuable	NULL
sites	NULL
for	NULL
therapeutic	NULL
intervention	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
Platelet-activating	NULL
factor	NULL
(	NULL
C-16	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Calbiochem	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cholera	NULL
and	NULL
pertussis	NULL
toxins	NULL
were	NULL
from	NULL
List	NULL
Laboratory	NULL
(	NULL
Campbell	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
was	NULL
isolated	NULL
from	NULL
lyophilized	NULL
Salmonella	NULL
minnesota	NULL
ReS95	NULL
bacteria	NULL
.	NULL

The	NULL
PI3-kinase	NULL
inhibitor	NULL
LY294002	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Chris	NULL
Vlahos	NULL
(	NULL
Eli	NULL
Lilly	NULL
&	NULL
Company	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
the	NULL
subunits	NULL
of	NULL
NF	NULL
«	NULL
B/Rel	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

An	NULL
antibody	NULL
against	NULL
a	NULL
COOH-terminal	NULL
peptide	NULL
(	NULL
residues	NULL
289-317	NULL
)	NULL
of	NULL
IkxBa	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Warner	NULL
C.	NULL
Greene	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
mouse	NULL
IxB	NULL
cDNA	NULL
and	NULL
the	NULL
I	NULL
«	NULL
B-CAT	NULL
constructs	NULL
(	NULL
6	NULL
)	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Inder	NULL
M.	NULL
Verma	NULL
(	NULL
The	NULL
Salk	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
and	NULL
their	NULL
complementary	NULL
strands	NULL
were	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

The	NULL
sequences	NULL
are	NULL
:	NULL
murine	NULL
intronic	NULL
«	NULL
chain	NULL
«	NULL
B	NULL
site	NULL
(	NULL
underlined	NULL
)	NULL
,	NULL
5-AGTTGAGGGGACTTITTCCCAGGC-3	NULL
'	NULL
(	NULL
NFkB	NULL
)	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
a	NULL
mutant	NULL
«	NULL
B	NULL
site	NULL
with	NULL
the	NULL
G	NULL
-	NULL
C	NULL
substitution	NULL
(	NULL
underlined	NULL
)	NULL
in	NULL
the	NULL
NF	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
mo-tif	NULL
,	NULL
5S'-AGTTGAGGCGACTTTCCCAGGC-3	NULL
'	NULL
.	NULL

YE	NULL
ET	NULL
AL	NULL
.	NULL

Double-stranded	NULL
oligonucleotide	NULL
(	NULL
5	NULL
pmol	NULL
)	NULL
was	NULL
P-labeled	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

Preparation	NULL
of	NULL
Monocytes	NULL
From	NULL
Peripheral	NULL
Blood	NULL
Heparinized	NULL
human	NULL
peripheral	NULL
blood	NULL
from	NULL
healthy	NULL
donors	NULL
was	NULL
fractionated	NULL
on	NULL
Percoll	NULL
density	NULL
gradients	NULL
.	NULL

The	NULL
separated	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
monocytes	NULL
were	NULL
isolated	NULL
using	NULL
gela-tin/plasma-coated	NULL
flasks	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
monocytes	NULL
was	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
as	NULL
determined	NULL
by	NULL
staining	NULL
with	NULL
the	NULL
anti-CD14	NULL
Ab	NULL
MY4	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
greater	NULL
than	NULL
98	NULL
%	NULL
as	NULL
measured	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Monocytes	NULL
were	NULL
resuspended	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
(	NULL
Irvine	NULL
Scientific	NULL
)	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

RNA	NULL
Extraction	NULL
and	NULL
Northern	NULL
Blotting	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
monocytes	NULL
by	NULL
a	NULL
modified	NULL
guanidinium-acetic	NULL
phenol	NULL
method	NULL
(	NULL
7	NULL
)	NULL
.	NULL

About	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
in	NULL
agarose	NULL
gels	NULL
containing	NULL
6	NULL
%	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
to	NULL
the	NULL
Hybond-N	NULL
plus	NULL
membranes	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

A	NULL
616-bp	NULL
HindIII-Xbal	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
HB-EGF	NULL
cDNA	NULL
was	NULL
synthesized	NULL
from	NULL
U937	NULL
total	NULL
RNA	NULL
by	NULL
reverse	NULL
tran-scriptase	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
hybridization	NULL
,	NULL
the	NULL
fragment	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
P	NULL
]	NULL
dATP	NULL
to	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
>	NULL
5	NULL
x	NULL
10°	NULL
cpm/ug	NULL
DNA	NULL
,	NULL
by	NULL
random	NULL
priming	NULL
.	NULL

Blots	NULL
were	NULL
prehybridized	NULL
in	NULL
6	NULL
x	NULL
SSC	NULL
,	NULL
5	NULL
x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
65°C	NULL
for	NULL
2	NULL
h	NULL
and	NULL
further	NULL
hybridized	NULL
with	NULL
the	NULL
P-labeled	NULL
probe	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
cpm/ml	NULL
!	NULL
)	NULL

for	NULL
16	NULL
h	NULL
at	NULL
the	NULL
same	NULL
temperature	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
with	NULL
2	NULL
x	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
65°C	NULL
,	NULL
followed	NULL
by	NULL
another	NULL
wash	NULL
with	NULL
0.1	NULL
x	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
.	NULL

Relative	NULL
hybridization	NULL
was	NULL
analyzed	NULL
for	NULL
quantitation	NULL
of	NULL
actual	NULL
radioactivity	NULL
by	NULL
a	NULL
phosphorImaging	NULL
System	NULL
(	NULL
Molecular	NULL
Dy-namics	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
quantity	NULL
of	NULL
samples	NULL
in	NULL
each	NULL
lane	NULL
was	NULL
standardized	NULL
against	NULL
relative	NULL
staining	NULL
of	NULL
the	NULL
188	NULL
and	NULL
28S	NULL
RNA	NULL
after	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
modified	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
9	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
harvested	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
0.4	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmeth-ylsulfonyl	NULL
fluoride	NULL
)	NULL
.	NULL

After	NULL
10	NULL
min	NULL
,	NULL
23	NULL
ul	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
and	NULL
mixed	NULL
for	NULL
2	NULL
s.	NULL
Nuclei	NULL
were	NULL
separated	NULL
from	NULL
cytosol	NULL
by	NULL
centrifugation	NULL
at	NULL
CHEMOATTRACTANT-INDUCED	NULL
GENE	NULL
EXPRESSION	NULL
207	NULL
Dose	NULL
(	NULL
nM	NULL
)	NULL
-	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
g.	NULL
het	NULL
o	NULL
.	NULL

o	NULL
o	NULL
2	NULL
o	NULL
Oo	NULL
~	NULL
~	NULL
~-	NULL
©	NULL
©	NULL
N	NULL
A	NULL
288	NULL
>	NULL
«	NULL
a	NULL
as	NULL
wi	NULL
#	NULL
#	NULL
18s	NULL
>	NULL
*	NULL
B	NULL
288	NULL
>	NULL
18s	NULL
>	NULL
«	NULL
dae	NULL
dis	NULL
WB	NULL
<	NULL
iL-1	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Accumulation	NULL
of	NULL
cytoplasmic	NULL
RNA	NULL
in	NULL
PAF-stimulated	NULL
monocytes	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
monocytes	NULL
was	NULL
prepared	NULL
after	NULL
stimulation	NULL
with	NULL
PAF	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
for	NULL
various	NULL
times	NULL
or	NULL
for	NULL
1	NULL
h	NULL
at	NULL
different	NULL
concentrations	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
the	NULL
total	NULL
RNA	NULL
was	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
and	NULL
probed	NULL
with	NULL
cDNA	NULL
for	NULL
HB-EGF	NULL
(	NULL
A	NULL
)	NULL
or	NULL
IL-1	NULL
$	NULL
6	NULL
(	NULL
B	NULL
)	NULL
.	NULL

13,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
s	NULL
and	NULL
were	NULL
resuspended	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
0.1	NULL
mM	NULL
PMSF	NULL
)	NULL
.	NULL

After	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
lysate	NULL
was	NULL
separated	NULL
by	NULL
centrifugation	NULL
(	NULL
13,000	NULL
x	NULL
g	NULL
,	NULL
30	NULL
s	NULL
)	NULL
and	NULL
supernatants	NULL
3	NULL
PAF	NULL
dose	NULL
(	NULL
nM	NULL
)	NULL
PAF	NULL
time	NULL
(	NULL
min	NULL
)	NULL
``	NULL
6	NULL
4T	NULL
u	NULL
a	NULL
®	NULL
0	NULL
5	NULL
-	NULL
o	NULL
scan	NULL
ko	NULL
&	NULL
=	NULL
&	NULL
2	NULL
%	NULL
g	NULL
.e	NULL
8.g	NULL
ts	NULL
S	NULL
[	NULL
|	NULL
won	NULL
-	NULL
awe	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Induction	NULL
of	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
PAF-stimulated	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
PAF	NULL
(	NULL
0.01-100	NULL
nM	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
,	NULL
TNF-a	NULL
(	NULL
40	NULL
ng/	NULL
ml	NULL
)	NULL
,	NULL
and	NULL
LPS	NULL
(	NULL
0.1	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
40	NULL
min	NULL
or	NULL
as	NULL
indicated	NULL
,	NULL
before	NULL
preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

A	NULL
P-labeled	NULL
21	NULL
mer	NULL
,	NULL
containing	NULL
the	NULL
consensus	NULL
«	NULL
B	NULL
site	NULL
(	NULL
GGGACTTTCC	NULL
)	NULL
,	NULL
was	NULL
used	NULL
for	NULL
EMSA	NULL
.	NULL

An	NULL
autoradiograph	NULL
of	NULL
EMSA	NULL
data	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
gel-retarded	NULL
DNA-protein	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
bracket	NULL
.	NULL

containing	NULL
nuclear	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
new	NULL
vials	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
extracts	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
BCA	NULL
reagents	NULL
(	NULL
Bio-Rad	NULL
)	NULL
with	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
standard	NULL
and	NULL
samples	NULL
were	NULL
diluted	NULL
to	NULL
equal	NULL
concentration	NULL
in	NULL
buffer	NULL
B	NULL
for	NULL
use	NULL
directly	NULL
or	NULL
storage	NULL
at	NULL
-80°C	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
incubating	NULL
2.5	NULL
ug	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
in	NULL
12	NULL
ul	NULL
of	NULL
binding	NULL
buffer	NULL
[	NULL
5	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.4	NULL
mg/ml	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
0.1	NULL
mg/ml	NULL
sonicated	NULL
double-stranded	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
]	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Then	NULL
approximately	NULL
20-50	NULL
fmol	NULL
of	NULL
P-labeled	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
30,000-50,000	NULL
PDTC	NULL
(	NULL
uM	NULL
)	NULL
O	NULL
o	NULL
o	NULL
0	NULL
N	NULL
N	NULL
[	NULL
Wo	NULL
=	NULL
28S	NULL
>	NULL
wee	NULL
18S	NULL
o	NULL
>	NULL
B	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Inhibition	NULL
of	NULL
PAF-induced	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
and	NULL
HB-EGF	NULL
gene	NULL
expression	NULL
by	NULL
PDTC	NULL
.	NULL

(	NULL
A	NULL
)	NULL
PDTC	NULL
inhibits	NULL
PAF-induced	NULL
xB	NULL
binding	NULL
activity	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
monocytes	NULL
preincubated	NULL
for	NULL
40	NULL
min	NULL
with	NULL
PDTC	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
,	NULL
followed	NULL
by	NULL
PAF	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
stimulation	NULL
for	NULL
60	NULL
min	NULL
.	NULL

The	NULL
autoradiograph	NULL
of	NULL
an	NULL
EMSA	NULL
result	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
PDTC	NULL
inhibits	NULL
PAF-induced	NULL
HB-EGF	NULL
gene	NULL
expression	NULL
.	NULL

Cells	NULL
pretreated	NULL
with	NULL
PDTC	NULL
,	NULL
as	NULL
indicated	NULL
above	NULL
,	NULL
were	NULL
stimulated	NULL
with	NULL
PAF	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
for	NULL
60	NULL
min	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
for	NULL
Northern	NULL
blot	NULL
as	NULL
described	NULL
.	NULL

The	NULL
autoradiograph	NULL
of	NULL
a	NULL
Northern	NULL
blot	NULL
is	NULL
shown	NULL
with	NULL
positions	NULL
of	NULL
the	NULL
ribo-somal	NULL
RNAs	NULL
indicated	NULL
.	NULL

208	NULL
YE	NULL
ET	NULL
AL	NULL
.	NULL

PAF	NULL
TNF	NULL
T	NULL
I	NULL
_I	NULL
=	NULL
o	NULL
w	NULL
P	NULL
=	NULL
o	NULL
in	NULL
®	NULL
0	NULL
&	NULL
€	NULL
6	NULL
0	NULL
4	NULL
€	NULL
5	NULL
1	NULL
_	NULL
2	NULL
3	NULL
4	NULL
5	NULL
106	NULL
co	NULL
-was	NULL
.	NULL

wn	NULL
w	NULL
@	NULL
.	NULL

33	NULL
28	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Identification	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
in	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
induced	NULL
by	NULL
PAF	NULL
.	NULL

A	NULL
P-labeled	NULL
probe	NULL
containing	NULL
BrdU	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
PAF-	NULL
and	NULL
TNF-stimulated	NULL
CHO-PAFR	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
in	NULL
EMSA	NULL
gel	NULL
were	NULL
UV	NULL
cross-linked	NULL
,	NULL
excised	NULL
,	NULL
eluted	NULL
,	NULL
and	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

In	NULL
separate	NULL
experiments	NULL
,	NULL
UV	NULL
cross-linked	NULL
samples	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
nonspecific	NULL
(	NULL
Ctrl	NULL
,	NULL
shown	NULL
in	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
)	NULL
or	NULL
specific	NULL
antibodies	NULL
against	NULL
three	NULL
members	NULL
of	NULL
the	NULL
NFxB/Rel	NULL
family	NULL
of	NULL
proteins	NULL
as	NULL
noted	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

cpm	NULL
)	NULL
was	NULL
added	NULL
and	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
analyzed	NULL
on	NULL
5	NULL
%	NULL
or	NULL
6	NULL
%	NULL
acrylamide	NULL
gels	NULL
,	NULL
which	NULL
were	NULL
made	NULL
in	NULL
50	NULL
mM	NULL
Tris-borate	NULL
buffer	NULL
containing	NULL
1	NULL
mM	NULL
EDTA	NULL
(	NULL
TBE	NULL
)	NULL
or	NULL
50	NULL
mM	NULL
Tris/380	NULL
mM	NULL
glycine/2	NULL
mM	NULL
EDTA	NULL
(	NULL
TGE	NULL
buffer	NULL
)	NULL
and	NULL
were	NULL
preelectrophoresed	NULL
for	NULL
2	NULL
h	NULL
at	NULL
12	NULL
V/cm	NULL
.	NULL

Electrophoresis	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
the	NULL
same	NULL
voltage	NULL
for	NULL
2-2.5	NULL
h.	NULL
Gel	NULL
contents	NULL
were	NULL
dried	NULL
on	NULL
What-man	NULL
DE-81	NULL
paper	NULL
and	NULL
exposed	NULL
for	NULL
3-5	NULL
h	NULL
at	NULL
-	NULL
80°C	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Chloramphenicol	NULL
Acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
Assay	NULL
Five	NULL
micrograms	NULL
each	NULL
of	NULL
the	NULL
IxBa	NULL
promoter-CAT	NULL
plasmids	NULL
pO.2kb	NULL
(	NULL
WT	NULL
)	NULL
CAT	NULL
and	NULL
pO.2kb	NULL
(	NULL
M	NULL
)	NULL
-CAT	NULL
(	NULL
6	NULL
)	NULL
and	NULL
the	NULL
pSVLCAT	NULL
plasmid	NULL
were	NULL
separately	NULL
transfected	NULL
into	NULL
CHO-PAFR	NULL
cells	NULL
,	NULL
together	NULL
with	NULL
1	NULL
ug	NULL
pCMV	NULL
$	NULL
B	NULL
plasmid	NULL
(	NULL
Clonetech	NULL
)	NULL
,	NULL
by	NULL
using	NULL
the	NULL
cationic	NULL
lipid	NULL
DOTAP	NULL
(	NULL
Boehringer	NULL
Mann-heim	NULL
)	NULL
.	NULL

Seven	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
stimulated	NULL
with	NULL
agonists	NULL
for	NULL
2	NULL
h	NULL
,	NULL
and	NULL
collected	NULL
for	NULL
CAT	NULL
assay	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
measured	NULL
in	NULL
crude	NULL
cellular	NULL
extracts	NULL
using	NULL
[	NULL
``	NULL
*C	NULL
)	NULL
chloram-phenicol	NULL
(	NULL
Amersham	NULL
)	NULL
as	NULL
substrate	NULL
,	NULL
followed	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
.	NULL

The	NULL
relative	NULL
transfec-tion	NULL
efficiency	NULL
was	NULL
determined	NULL
by	NULL
measurement	NULL
of	NULL
coexpressed	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

Ultraviolet	NULL
(	NULL
UV	NULL
)	NULL
Cross-Linking	NULL
Analysis	NULL
Double-stranded	NULL
*P	NULL
radiolabeled	NULL
photoreac-tive	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
the	NULL
«	NULL
B	NULL
site	NULL
Time	NULL
(	NULL
min	NULL
.	NULL
)	NULL

UD	NULL
_	NULL
©	NULL
O	NULL
-	NULL
&	NULL
M	NULL
[	NULL
«	NULL
]	NULL
&	NULL
W	NULL
©	NULL
NF-kB	NULL
[	NULL
Cytosolic	NULL
;	NULL
IkB	NULL
level	NULL
9	NULL
meen	NULL
IkB	NULL
§	NULL
message	NULL
-	NULL
>	NULL
|	NULL
/_	NULL
GAPDH	NULL
message	NULL
ne	NULL
me	NULL
me	NULL
me	NULL
wus	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Time-dependent	NULL
stimulation	NULL
of	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

Shown	NULL
are	NULL
simultaneous	NULL
measurements	NULL
of	NULL
NFxB	NULL
activation	NULL
by	NULL
EMSA	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
,	NULL
cytosolic	NULL
I	NULL
«	NULL
B	NULL
content	NULL
by	NULL
Western	NULL
blot	NULL
(	NULL
second	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
the	NULL
message	NULL
for	NULL
IxB	NULL
by	NULL
Northern	NULL
blot	NULL
(	NULL
third	NULL
panel	NULL
)	NULL
,	NULL
as	NULL
a	NULL
function	NULL
of	NULL
time	NULL
after	NULL
stimulation	NULL
with	NULL
10	NULL
nM	NULL
PAF	NULL
.	NULL

GAPDH	NULL
was	NULL
used	NULL
as	NULL
a	NULL
mRNA	NULL
control	NULL
.	NULL

CHEMOATTRACTANT-INDUCED	NULL
GENE	NULL
EXPRESSION	NULL
209	NULL
p0.2kb	NULL
(	NULL
WT	NULL
)	NULL
CAT	NULL
p0.2kb	NULL
(	NULL
M	NULL
)	NULL
CAT	NULL
u	NULL
pSVLCAT	NULL
AcCM	NULL
e	NULL
CM	NULL
-_	NULL
amy	NULL
,	NULL
Fold	NULL
Activation	NULL
13	NULL
1	NULL
PAF	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
tek	NULL
lus	NULL
TNF	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

ral	NULL
iw	NULL
F	NULL
1	NULL
8	NULL
14	NULL
-	NULL
N.D.	NULL
N.D.	NULL
N.D.	NULL
4	NULL
=	NULL
=	NULL
+	NULL
a=	NULL
=	NULL
+	NULL
=	NULL
=	NULL
+	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

PAF-	NULL
and	NULL
TNF-	NULL
«	NULL
-induced	NULL
IkBa	NULL
promoter-directed	NULL
CAT	NULL
gene	NULL
expression	NULL
in	NULL
transiently	NULL
transfected	NULL
CHO-PAFR	NULL
cells	NULL
.	NULL

CHO-PAFR	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
IxBa	NULL
promoter-CAT	NULL
reporter	NULL
plasmids	NULL
(	NULL
specified	NULL
at	NULL
the	NULL
top	NULL
)	NULL
or	NULL
5	NULL
ug	NULL
of	NULL
pSVLCAT	NULL
plasmid	NULL
,	NULL
together	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
plasmid	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
these	NULL
cells	NULL
after	NULL
stimulation	NULL
of	NULL
PAF	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
here	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
CAT	NULL
assays	NULL
.	NULL

N.D.	NULL
:	NULL
not	NULL
detectable	NULL
.	NULL

was	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
4,21	NULL
)	NULL
.	NULL

UV	NULL
cross-linking	NULL
was	NULL
performed	NULL
in	NULL
solution	NULL
by	NULL
irradiation	NULL
(	NULL
300	NULL
nm	NULL
,	NULL
7000-mW/cm	NULL
illuminator	NULL
,	NULL
Fotodyne	NULL
)	NULL
of	NULL
the	NULL
respective	NULL
binding	NULL
reaction	NULL
with	NULL
10	NULL
ug	NULL
nuclear	NULL
extract	NULL
and	NULL
[	NULL
P	NULL
]	NULL
BrdU	NULL
(	NULL
5'-bromo-2'-deoxyuridine	NULL
5'-triphosphate	NULL
)	NULL
«	NULL
B-probe	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
UV	NULL
cross-linking	NULL
,	NULL
the	NULL
oligonucleotide-protein	NULL
adduct	NULL
was	NULL
boiled	NULL
for	NULL
2	NULL
min	NULL
in	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
diluted	NULL
fivefold	NULL
with	NULL
TSN	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
by	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
normal	NULL
rabbit	NULL
IgG	NULL
or	NULL
anti-p50	NULL
,	NULL
anti-p65	NULL
,	NULL
and	NULL
anti-c-Rel	NULL
antibodies	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
``	NULL
P-labeled	NULL
products	NULL
were	NULL
directly	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
8	NULL
%	NULL
discontinuous	NULL
gel	NULL
)	NULL
under	NULL
reducing	NULL
conditions	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
a	NULL
[	NULL
P	NULL
]	NULL
BrdU	NULL
probe	NULL
binding	NULL
protein	NULL
complexes	NULL
were	NULL
UV	NULL
cross-linked	NULL
in	NULL
native	NULL
EMSA	NULL
gel	NULL
,	NULL
excised	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Immunoblotting	NULL
Approximately	NULL
10	NULL
ug	NULL
of	NULL
cytoplasmic	NULL
extracts	NULL
,	NULL
collected	NULL
after	NULL
the	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
and	NULL
centrifugation	NULL
steps	NULL
,	NULL
was	NULL
mixed	NULL
with	NULL
loading	NULL
dye	NULL
,	NULL
boiled	NULL
,	NULL
electrophoresed	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS	NULL
gel	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
Hybond-ECL	NULL
nitrocellulose	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Filter	NULL
strips	NULL
were	NULL
incubated	NULL
with	NULL
primary	NULL
antibody	NULL
against	NULL
the	NULL
IkxBa	NULL
carboxyl-terminus	NULL
(	NULL
1	NULL
:	NULL
2500	NULL
dilution	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
followed	NULL
by	NULL
addition	NULL
of	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
at	NULL
1:10,000	NULL
for	NULL
30	NULL
min	NULL
and	NULL
analysis	NULL
with	NULL
enhanced	NULL
chemiluminescence	NULL
reagents	NULL
(	NULL
Du	NULL
Pont-NEN	NULL
)	NULL
.	NULL

RESULTS	NULL
Chemoattractant	NULL
receptors	NULL
belong	NULL
to	NULL
the	NULL
super-family	NULL
of	NULL
G-protein-coupled	NULL
receptors	NULL
with	NULL
seven	NULL
putative	NULL
transmembrane	NULL
domains	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Agonist	NULL
binding	NULL
of	NULL
the	NULL
receptors	NULL
triggers	NULL
a	NULL
series	NULL
of	NULL
signaling	NULL
events	NULL
leading	NULL
to	NULL
specific	NULL
leukocyte	NULL
functions	NULL
(	NULL
30	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
chemoattractants	NULL
directly	NULL
stimulate	NULL
transcription	NULL
activation	NULL
,	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
PAF	NULL
,	NULL
and	NULL
the	NULL
subsequent	NULL
changes	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
message	NULL
for	NULL
heparin	NULL
binding	NULL
EGF-like	NULL
growth	NULL
factor	NULL
(	NULL
HB-EGF	NULL
)	NULL
were	NULL
measured	NULL
.	NULL

PAF	NULL
,	NULL
a	NULL
lipid	NULL
chemoattrac-tant	NULL
,	NULL
induced	NULL
an	NULL
elevation	NULL
of	NULL
the	NULL
HB-EGF	NULL
message	NULL
in	NULL
a	NULL
dose-	NULL
and	NULL
time-dependent	NULL
fashion	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
PAF	NULL
stimulated	NULL
the	NULL
upregulation	NULL
of	NULL
the	NULL
message	NULL
for	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
was	NULL
known	NULL
to	NULL
be	NULL
regulated	NULL
in	NULL
part	NULL
by	NULL
the	NULL
transcription	NULL
activator	NULL
NFkB	NULL
(	NULL
8	NULL
)	NULL
,	NULL
although	NULL
it	NULL
was	NULL
not	NULL
clear	NULL
how	NULL
HB-EGF	NULL
gene	NULL
expression	NULL
was	NULL
regulated	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PAF	NULL
on	NULL
NFkB	NULL
was	NULL
then	NULL
examined	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
at	NULL
210	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
5	NULL
15	NULL
30	NULL
60	NULL
150	NULL
300	NULL
pas	NULL
8B	NULL
|	NULL
_|	NULL
NFKB	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
PAF-induced	NULL
NFxB	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
and	NULL
AP-1	NULL
binding	NULL
activity	NULL
in	NULL
CHO-PAFR	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
100	NULL
nM	NULL
PAF	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Radiolabeled	NULL
probes	NULL
with	NULL
the	NULL
«	NULL
B	NULL
site	NULL
and	NULL
AP-1	NULL
site	NULL
were	NULL
incubated	NULL
separately	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
and	NULL
analyzed	NULL
by	NULL
SDS	NULL
gel	NULL
.	NULL

Note	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
time	NULL
course	NULL
for	NULL
the	NULL
induced	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
binding	NULL
activities	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
by	NULL
others	NULL
.	NULL

nanomolar	NULL
concentrations	NULL
PAF	NULL
activated	NULL
NFKB	NULL
to	NULL
an	NULL
extent	NULL
similar	NULL
to	NULL
the	NULL
previously	NULL
characterized	NULL
activators	NULL
TNF-	NULL
«	NULL
and	NULL
PMA	NULL
.	NULL

The	NULL
time	NULL
course	NULL
of	NULL
these	NULL
responses	NULL
suggested	NULL
that	NULL
PAF-stimulated	NULL
NFB	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
elevated	NULL
message	NULL
levels	NULL
.	NULL

This	NULL
notion	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
inhibitor	NULL
for	NULL
NFB	NULL
,	NULL
pyrrolidine	NULL
dithi-ocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
,	NULL
dose-dependently	NULL
blocked	NULL
PAF-induced	NULL
NFxB	NULL
activation	NULL
as	NULL
well	NULL
as	NULL
elevation	NULL
of	NULL
the	NULL
HB-EGF	NULL
message	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

A	NULL
stably	NULL
transfected	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
cell	NULL
line	NULL
expressing	NULL
the	NULL
PAF	NULL
receptor	NULL
(	NULL
CHO-PAFR	NULL
cell	NULL
)	NULL
was	NULL
employed	NULL
for	NULL
further	NULL
characterization	NULL
of	NULL
PAF-induced	NULL
NFkB	NULL
activation	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
PAF	NULL
stimulation	NULL
of	NULL
NFB	NULL
activation	NULL
requires	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
specific	NULL
PAF	NULL
receptor	NULL
,	NULL
which	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
two	NULL
PAF	NULL
antagonists	NULL
tested	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PAF-induced	NULL
NFkB	NULL
activation	NULL
involves	NULL
nuclear	NULL
translocation	NULL
of	NULL
p50/p65	NULL
,	NULL
but	NULL
not	NULL
c-rel	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
UV	NULL
cross	NULL
YE	NULL
ET	NULL
AL	NULL
.	NULL

linking	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
other	NULL
inducers	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
,	NULL
PAF-induced	NULL
NFxB	NULL
activation	NULL
in	NULL
CHO	NULL
cells	NULL
is	NULL
preceded	NULL
by	NULL
IxB	NULL
degradation	NULL
followed	NULL
by	NULL
resynthesis	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

PAF	NULL
stimulated	NULL
not	NULL
only	NULL
a	NULL
DNA	NULL
binding	NULL
activity	NULL
but	NULL
also	NULL
transcription	NULL
activation	NULL
in	NULL
CHO	NULL
cells	NULL
as	NULL
detected	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
6	NULL
)	NULL
with	NULL
a	NULL
«	NULL
B	NULL
site	NULL
from	NULL
the	NULL
IxB	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
provided	NULL
detailed	NULL
information	NULL
about	NULL
NFB	NULL
activation	NULL
induced	NULL
by	NULL
a	NULL
G-protein-coupled	NULL
chemoattractant	NULL
receptor	NULL
.	NULL

Using	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
radiolabeled	NULL
probe	NULL
containing	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
,	NULL
it	NULL
was	NULL
observed	NULL
that	NULL
PAF	NULL
induced	NULL
AP-1	NULL
activity	NULL
in	NULL
the	NULL
CHO-PAFR	NULL
cells	NULL
,	NULL
although	NULL
with	NULL
a	NULL
different	NULL
response	NULL
time	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
the	NULL
activated	NULL
NFB	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Results	NULL
derived	NULL
from	NULL
the	NULL
above	NULL
studies	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
capability	NULL
of	NULL
other	NULL
chemoattractants	NULL
to	NULL
regulate	NULL
gene	NULL
transcription	NULL
.	NULL

Selected	NULL
chemoattractants	NULL
were	NULL
employed	NULL
in	NULL
a	NULL
study	NULL
with	NULL
freshly	NULL
isolated	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
are	NULL
known	NULL
to	NULL
express	NULL
recep-	NULL
vam	NULL
-~	NULL
E	NULL
~	NULL
EEEAAE	NULL
g	NULL
’	NULL
CQEEc	NULL
g	NULL
6	NULL
.	NULL

``	NULL
6	NULL
.	NULL

=	NULL
s.	NULL
a	NULL
~-	NULL
_o	NULL
Axt	NULL
3	NULL
C	NULL
5E¢	NULL
2	NULL
€	NULL
6	NULL
<	NULL
I	NULL
u	NULL
OA	NULL
_d	NULL
8	NULL
s	NULL
@	NULL
4	NULL
o	NULL
S5	NULL
°	NULL
i	NULL
2	NULL
A	NULL
J	NULL
a	NULL
E	NULL
0	NULL
-	NULL
E	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Induction	NULL
of	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
by	NULL
several	NULL
chemoattractants	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
45	NULL
min	NULL
with	NULL
five	NULL
chemoattractants	NULL
,	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
.	NULL

As	NULL
controls	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
also	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
and	NULL
LPS	NULL
.	NULL

Shown	NULL
is	NULL
an	NULL
autoradiograph	NULL
of	NULL
the	NULL
EMSA	NULL
result	NULL
.	NULL

CHEMOATTRACTANT-INDUCED	NULL
GENE	NULL
EXPRESSION	NULL
211	NULL
A	NULL
hs	NULL
IL-8	NULL
ae	NULL
IL-8	NULL
IL-8	NULL
(	NULL
nM	NULL
)	NULL
Receptor	NULL
m	NULL
m	NULL
m	NULL
0	NULL
1	NULL
10	NULL
20	NULL
(	NULL
UY	NULL
U	NULL
)	NULL
C	NULL
Xvation	NULL
IL-8	NULL
A	NULL
Protein	NULL
N	NULL
synthesis	NULL
Translational	NULL
Protein	NULL
Phosphorylation	NULL
regulation	NULL
?	NULL

degradation	NULL
of	NULL
IkB	NULL
/	NULL
4	NULL
o	NULL
}	NULL
V	NULL
-	NULL
Ges	NULL
]	NULL
$	NULL
=	NULL
,	NULL
I'kB	NULL
‘	NULL
x_	NULL
IL-8	NULL
mRNA	NULL
—	NULL
--	NULL
-	NULL
:	NULL
_	NULL
,	NULL
-	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
``	NULL
*kg	NULL
/\/\/\/\	NULL
>	NULL
*	NULL
.	NULL

{	NULL
APA	NULL
)	NULL
--	NULL
[	NULL
[	NULL
kB-ike	NULL
}	NULL
-	NULL
~	NULL
,	NULL
``	NULL
IL-8	NULL
gene	NULL
4	NULL
Pos	NULL
sarap	NULL
Lai	NULL
&	NULL
Monocyte	NULL
>	NULL
°	NULL
;	NULL
\	NULL
/	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Potential	NULL
autocrine	NULL
regulation	NULL
of	NULL
IL-8	NULL
synthesis	NULL
.	NULL

Left	NULL
:	NULL
schematic	NULL
representation	NULL
of	NULL
a	NULL
possible	NULL
autocrine	NULL
mechanism	NULL
for	NULL
IL-8-stimulated	NULL
IL-8	NULL
production	NULL
.	NULL

Right	NULL
:	NULL
autoradiographs	NULL
of	NULL
an	NULL
EMSA	NULL
(	NULL
top	NULL
)	NULL
showing	NULL
IL-8	NULL
induced	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
,	NULL
and	NULL
of	NULL
a	NULL
Northern	NULL
blot	NULL
(	NULL
bottom	NULL
)	NULL
depicting	NULL
the	NULL
accumulation	NULL
of	NULL
cytoplasmic	NULL
IL-8	NULL
message	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
.	NULL

Freshly	NULL
isolated	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IL-8	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
for	NULL
1	NULL
h	NULL
before	NULL
harvesting	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
nuclear	NULL
extracts	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

tors	NULL
for	NULL
a	NULL
large	NULL
number	NULL
of	NULL
chemoattractants	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
ones	NULL
used	NULL
for	NULL
the	NULL
study	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
mononuclear	NULL
cells	NULL
responded	NULL
to	NULL
three	NULL
classical	NULL
chemoattractants	NULL
and	NULL
two	NULL
chemokines	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
detected	NULL
by	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
radiolabeled	NULL
«	NULL
kB	NULL
probe	NULL
.	NULL

Further	NULL
studies	NULL
with	NULL
selected	NULL
chemoattractants	NULL
produced	NULL
dose	NULL
and	NULL
time	NULL
response	NULL
data	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
similar	NULL
to	NULL
those	NULL
obtained	NULL
previously	NULL
with	NULL
PAF	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
induction	NULL
of	NULL
gene	NULL
transcription	NULL
may	NULL
be	NULL
a	NULL
general	NULL
property	NULL
of	NULL
chemoattractants	NULL
.	NULL

The	NULL
two	NULL
chemokines	NULL
(	NULL
IL-8	NULL
and	NULL
MCP-1	NULL
)	NULL
tested	NULL
in	NULL
the	NULL
above	NULL
experiments	NULL
belong	NULL
to	NULL
the	NULL
CXC	NULL
and	NULL
CC	NULL
chemokine	NULL
subgroups	NULL
,	NULL
respectively	NULL
.	NULL

Biosynthesis	NULL
of	NULL
these	NULL
chemokines	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
a	NULL
number	NULL
of	NULL
proinflammatory	NULL
stimuli	NULL
,	NULL
including	NULL
LPS	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
2	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
recently	NULL
that	NULL
expression	NULL
of	NULL
IL-8	NULL
and	NULL
MCP	NULL
is	NULL
regulated	NULL
mainly	NULL
at	NULL
the	NULL
transcription	NULL
level	NULL
(	NULL
18	NULL
)	NULL
.	NULL

NF	NULL
«	NULL
B	NULL
sites	NULL
or	NULL
similar	NULL
sequences	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
the	NULL
genes	NULL
encoding	NULL
IL-8	NULL
and	NULL
MCP-1	NULL
,	NULL
and	NULL
studies	NULL
using	NULL
CAT	NULL
reporter	NULL
constructs	NULL
have	NULL
shown	NULL
that	NULL
these	NULL
sites	NULL
contribute	NULL
to	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-8	NULL
and	NULL
MCP-1	NULL
genes	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
IL-8	NULL
and	NULL
MCP-1	NULL
themselves	NULL
are	NULL
capable	NULL
of	NULL
inducing	NULL
NFkB	NULL
activation	NULL
suggests	NULL
a	NULL
potential	NULL
autocrine	NULL
or	NULL
positive	NULL
regulatory	NULL
mechanism	NULL
for	NULL
the	NULL
biosynthesis	NULL
of	NULL
these	NULL
chemokines	NULL
,	NULL
as	NULL
depicted	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
preliminary	NULL
results	NULL
indicate	NULL
potentiation	NULL
of	NULL
the	NULL
IL-8	NULL
message	NULL
in	NULL
IL-8-stimulated	NULL
mononuclear	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

It	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
this	NULL
message	NULL
upregulation	NULL
is	NULL
accompanied	NULL
by	NULL
IL-8	NULL
protein	NULL
synthesis	NULL
.	NULL

Chemoattractant	NULL
receptors	NULL
are	NULL
G-protein-coupled	NULL
serpentine	NULL
receptors	NULL
and	NULL
,	NULL
as	NULL
such	NULL
,	NULL
they	NULL
may	NULL
utilize	NULL
signaling	NULL
mechanisms	NULL
different	NULL
from	NULL
those	NULL
employed	NULL
by	NULL
other	NULL
inducers	NULL
for	NULL
transcription	NULL
activation	NULL
.	NULL

PAF	NULL
treatment	NULL
of	NULL
transfected	NULL
CHO	NULL
cells	NULL
induces	NULL
NFkB	NULL
activation	NULL
that	NULL
requires	NULL
the	NULL
functional	NULL
coupling	NULL
of	NULL
the	NULL
receptor	NULL
with	NULL
G-proteins	NULL
,	NULL
as	NULL
cholera	NULL
toxin	NULL
effectively	NULL
blocks	NULL
this	NULL
effect	NULL
of	NULL
PAF	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
PAF-stimulated	NULL
responses	NULL
in	NULL
mononuclear	NULL
cells	NULL
were	NULL
refractory	NULL
to	NULL
cholera	NULL
toxin	NULL
treatment	NULL
.	NULL

Instead	NULL
,	NULL
pertussis	NULL
toxin	NULL
can	NULL
block	NULL
PAF-stimulated	NULL
HB-EGF	NULL
gene	NULL
expression	NULL
(	NULL
23	NULL
)	NULL
and	NULL
NFkB	NULL
activation	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
cell-specific	NULL
coupling	NULL
of	NULL
the	NULL
PAF	NULL
receptor	NULL
to	NULL
different	NULL
G-proteins	NULL
,	NULL
consistent	NULL
with	NULL
previous	NULL
results	NULL
from	NULL
other	NULL
studies	NULL
(	NULL
1,28	NULL
)	NULL
.	NULL

212	NULL
The	NULL
potential	NULL
signaling	NULL
pathways	NULL
employed	NULL
by	NULL
chemoattractants	NULL
were	NULL
compared	NULL
with	NULL
those	NULL
utilized	NULL
by	NULL
two	NULL
other	NULL
NFkB	NULL
inducers	NULL
,	NULL
TNF-a	NULL
and	NULL
PMA	NULL
.	NULL

Treatment	NULL
of	NULL
mononuclear	NULL
cells	NULL
with	NULL
the	NULL
protein	NULL
kinase	NULL
inhibitors	NULL
herbimycin	NULL
A	NULL
(	NULL
HA	NULL
)	NULL
and	NULL
staurosporine	NULL
(	NULL
STSP	NULL
)	NULL
blocked	NULL
PAF-induced	NULL
NFB	NULL
activation	NULL
,	NULL
while	NULL
having	NULL
no	NULL
effect	NULL
on	NULL
TNF-	NULL
«	NULL
-	NULL
and	NULL
PMA-induced	NULL
NFB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

11A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
two	NULL
inhibitors	NULL
for	NULL
the	NULL
phosphoinositol	NULL
3-kinase	NULL
(	NULL
PI3K	NULL
)	NULL
,	NULL
wortmannin	NULL
and	NULL
LY294002	NULL
,	NULL
selectively	NULL
blocked	NULL
PAF-induced	NULL
NFkB	NULL
activation	NULL
but	NULL
had	NULL
no	NULL
inhibitory	NULL
effect	NULL
on	NULL
the	NULL
TNF-	NULL
&	NULL
«	NULL
-	NULL
and	NULL
PMA-stimulated	NULL
responses	NULL
(	NULL
Fig	NULL
.	NULL

11B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
PAF	NULL
regulates	NULL
NFx	NULL
«	NULL
B	NULL
activity	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
G-proteins	NULL
,	NULL
protein	NULL
tyrosine	NULL
ki-nases	NULL
,	NULL
and	NULL
PI3K	NULL
.	NULL

DISCUSSION	NULL
A	NULL
large	NULL
number	NULL
of	NULL
proinflammatory	NULL
factors	NULL
are	NULL
synthesized	NULL
as	NULL
a	NULL
result	NULL
of	NULL
leukocyte	NULL
activation	NULL
.	NULL

PAF+PT	NULL
PAF	NULL
+CIT	NULL
-E	NULL
cC	NULL
(	NULL
ug/m	NULL
!	NULL
)	NULL

__	NULL
(	NULL
ug/mi	NULL
)	NULL
9-	NULL
ti	NULL
2	NULL
u	NULL
a	NULL
&	NULL
u	NULL
m	NULL
o	NULL
<	NULL
8	NULL
N	NULL
N	NULL
o	NULL
Z	NULL
Z	NULL
Z	NULL
0	NULL
m	NULL
0	NULL
o	NULL
~	NULL
0	NULL
~	NULL
N	NULL
-	NULL
-o-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Effect	NULL
of	NULL
bacterial	NULL
toxins	NULL
on	NULL
PAF-induced	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
CHO-PAFR	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
either	NULL
cholera	NULL
toxin	NULL
(	NULL
CT	NULL
)	NULL
or	NULL
pertussis	NULL
toxin	NULL
(	NULL
PT	NULL
)	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
for	NULL
4	NULL
h	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
ligands	NULL
for	NULL
40	NULL
min	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
concentrations	NULL
of	NULL
the	NULL
toxins	NULL
used	NULL
with	NULL
TNF-	NULL
«	NULL
were	NULL
2	NULL
ug/ml	NULL
(	NULL
PT	NULL
)	NULL
and	NULL
20	NULL
ug/ml	NULL
(	NULL
CT	NULL
)	NULL
.	NULL

The	NULL
ligand	NULL
concentrations	NULL
were	NULL
10	NULL
nM	NULL
(	NULL
PAF	NULL
)	NULL
and	NULL
40	NULL
ng/ml	NULL
(	NULL
TNF-a	NULL
)	NULL
.	NULL

Con-trol	NULL
:	NULL
without	NULL
ligand	NULL
stimulation	NULL
and	NULL
toxin	NULL
treatment	NULL
.	NULL

YE	NULL
ET	NULL
AL	NULL
.	NULL

Understanding	NULL
the	NULL
regulatory	NULL
mechanism	NULL
for	NULL
the	NULL
gene	NULL
expression	NULL
process	NULL
,	NULL
therefore	NULL
,	NULL
is	NULL
crucial	NULL
to	NULL
the	NULL
development	NULL
of	NULL
effective	NULL
therapeutic	NULL
agents	NULL
.	NULL

NFkB	NULL
and	NULL
AP-1	NULL
are	NULL
major	NULL
transcription	NULL
activators	NULL
that	NULL
control	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
immediate-early	NULL
genes	NULL
(	NULL
14,16	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
products	NULL
of	NULL
some	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
including	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
,	NULL
in	NULL
turn	NULL
stimulate	NULL
NFB	NULL
activation	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Data	NULL
from	NULL
the	NULL
current	NULL
study	NULL
expand	NULL
the	NULL
list	NULL
to	NULL
include	NULL
several	NULL
chemoattractants	NULL
.	NULL

These	NULL
are	NULL
agents	NULL
derived	NULL
from	NULL
various	NULL
sources	NULL
and	NULL
are	NULL
activators	NULL
of	NULL
leukocytes	NULL
during	NULL
inflammation	NULL
.	NULL

Thus	NULL
,	NULL
migrating	NULL
leukocytes	NULL
may	NULL
be	NULL
exposed	NULL
to	NULL
chemoattractants	NULL
that	NULL
induce	NULL
the	NULL
synthesis	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
before	NULL
the	NULL
cells	NULL
reach	NULL
the	NULL
inflammatory	NULL
sites	NULL
.	NULL

Previously	NULL
published	NULL
data	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
chemoattractants	NULL
stimulate	NULL
the	NULL
production	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
5,10	NULL
,	NULL
13,27,32	NULL
)	NULL
,	NULL
but	NULL
the	NULL
transcription	NULL
mechanisms	NULL
adopted	NULL
by	NULL
chemoattractant	NULL
have	NULL
not	NULL
been	NULL
under-stood	NULL
.	NULL

Chemoattractants	NULL
may	NULL
regulate	NULL
gene	NULL
transcription	NULL
with	NULL
different	NULL
modes	NULL
of	NULL
action	NULL
.	NULL

Apart	NULL
from	NULL
the	NULL
known	NULL
paracrine	NULL
and	NULL
the	NULL
potential	NULL
autocrine	NULL
mechanisms	NULL
discussed	NULL
above	NULL
,	NULL
juxtacrine	NULL
stimulation	NULL
is	NULL
used	NULL
by	NULL
PAF	NULL
.	NULL

Vascular	NULL
endothelial	NULL
cells	NULL
produce	NULL
cell-associated	NULL
PAF	NULL
upon	NULL
stimulation	NULL
with	NULL
inflammatory	NULL
agents	NULL
(	NULL
24,35	NULL
)	NULL
.	NULL

By	NULL
contacting	NULL
leukocytes	NULL
through	NULL
their	NULL
cell	NULL
surface	NULL
proteins	NULL
such	NULL
as	NULL
P-selectin	NULL
,	NULL
the	NULL
endothelial	NULL
cell-associated	NULL
PAF	NULL
may	NULL
interact	NULL
with	NULL
and	NULL
stimulate	NULL
the	NULL
PAF	NULL
receptor	NULL
on	NULL
leukocytes	NULL
(	NULL
36	NULL
)	NULL
.	NULL

This	NULL
function	NULL
of	NULL
PAF	NULL
,	NULL
combined	NULL
with	NULL
the	NULL
capability	NULL
of	NULL
PAF	NULL
to	NULL
induce	NULL
transcription	NULL
activators	NULL
,	NULL
is	NULL
likely	NULL
to	NULL
contribute	NULL
to	NULL
gene	NULL
expression	NULL
essential	NULL
for	NULL
the	NULL
development	NULL
of	NULL
several	NULL
pathological	NULL
conditions	NULL
,	NULL
including	NULL
atherosclerosis	NULL
.	NULL

PAF	NULL
stimulates	NULL
monocytes	NULL
to	NULL
express	NULL
HB-EGF	NULL
,	NULL
a	NULL
potent	NULL
mitogen	NULL
for	NULL
smooth	NULL
muscle	NULL
cells	NULL
,	NULL
and	NULL
IL-193	NULL
,	NULL
an	NULL
inflammatory	NULL
mediator	NULL
.	NULL

Both	NULL
proteins	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
contributing	NULL
factors	NULL
for	NULL
atherogene-sis	NULL
(	NULL
20,26	NULL
)	NULL
.	NULL

Chemoattractant	NULL
receptors	NULL
constitute	NULL
a	NULL
subgroup	NULL
within	NULL
the	NULL
G-protein-coupled	NULL
receptor	NULL
su-perfamily	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Several	NULL
G-protein-coupled	NULL
receptors	NULL
are	NULL
known	NULL
to	NULL
stimulate	NULL
gene	NULL
transcription	NULL
(	NULL
17,25	NULL
)	NULL
.	NULL

With	NULL
these	NULL
receptors	NULL
,	NULL
the	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
has	NULL
been	NULL
partially	NULL
delineated	NULL
(	NULL
34	NULL
)	NULL
.	NULL

PAF-induced	NULL
AP-1	NULL
activity	NULL
is	NULL
likely	NULL
to	NULL
employ	NULL
a	NULL
similar	NULL
mechanism	NULL
.	NULL

With	NULL
respect	NULL
to	NULL
NFB	NULL
activation	NULL
,	NULL
current	NULL
data	NULL
support	NULL
a	NULL
prototypic	NULL
model	NULL
that	NULL
involves	NULL
IkB	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
,	NULL
followed	NULL
by	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
p50/p65	NULL
heterodimer	NULL
(	NULL
12,16	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
kinases	NULL
that	NULL
phosphorylate	NULL
IxB	NULL
,	NULL
and	NULL
the	NULL
CHEMOATTRACTANT-INDUCED	NULL
GENE	NULL
EXPRESSION	NULL
213	NULL
Untreated	NULL
Herb	NULL
.	NULL

A	NULL
STSP	NULL
C	NULL
u	NULL
TG	NULL
u	NULL
G	NULL
u	NULL
<	NULL
4	NULL
C	NULL
u	NULL
4G	NULL
ou	NULL
®	NULL
®	NULL
0	NULL
=	NULL
i	NULL
&	NULL
E	NULL
$	NULL
$	NULL
E	NULL
E	NULL
$	NULL
f	NULL
P	NULL
Z	NULL
C	NULL
-	NULL
wa	NULL
an	NULL
w	NULL
#	NULL
@	NULL
@	NULL
-	NULL
#	NULL
8	NULL
an	NULL
uu	NULL
tp	NULL
ue	NULL
un	NULL
e	NULL
eh	NULL
s	NULL
0+	NULL
E	NULL
w	NULL
(	NULL
100nM	NULL
)	NULL
LY	NULL
(	NULL
50	NULL
,	NULL
M	NULL
)	NULL
3	NULL
Sass	NULL
r	NULL
el	NULL
g	NULL
k	NULL
k	NULL
s	NULL
B	NULL
k	NULL
§	NULL
5	NULL
k	NULL
§	NULL
-	NULL
A	NULL
A	NULL
-	NULL
A	NULL
A	NULL
b	NULL
oa	NULL
a	NULL
FIG	NULL
.	NULL

11	NULL
.	NULL

Selective	NULL
inhibition	NULL
of	NULL
PAF-induced	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
by	NULL
protein	NULL
kinase	NULL
inhibitors	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Autoradiograph	NULL
of	NULL
EMSA	NULL
showing	NULL
the	NULL
differential	NULL
effects	NULL
of	NULL
herbimycin	NULL
A	NULL
(	NULL
Herb	NULL
.	NULL

A	NULL
,	NULL
1	NULL
uM	NULL
)	NULL
and	NULL
staurosporine	NULL
(	NULL
STSP	NULL
,	NULL
200	NULL
nM	NULL
)	NULL
on	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
induced	NULL
by	NULL
PAF	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
(	NULL
40	NULL
ng/ml	NULL
)	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
inhibitors	NULL
for	NULL
30	NULL
min	NULL
followed	NULL
by	NULL
agonist	NULL
stimulation	NULL
for	NULL
1	NULL
h.	NULL
(	NULL
B	NULL
)	NULL
Similar	NULL
to	NULL
(	NULL
A	NULL
)	NULL
,	NULL
but	NULL
mononuclear	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
wortmannin	NULL
or	NULL
LY294002	NULL
for	NULL
5	NULL
min	NULL
before	NULL
agonist	NULL
stimulation	NULL
.	NULL

upstream	NULL
signaling	NULL
molecules	NULL
,	NULL
have	NULL
not	NULL
been	NULL
completely	NULL
identified	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
an	NULL
understanding	NULL
of	NULL
the	NULL
chemoattractant	NULL
receptor	NULL
signal	NULL
transduc-tion	NULL
pathway	NULL
may	NULL
provide	NULL
complementary	NULL
information	NULL
to	NULL
studies	NULL
with	NULL
other	NULL
receptor	NULL
systems	NULL
.	NULL

The	NULL
observed	NULL
differences	NULL
between	NULL
PAF	NULL
and	NULL
two	NULL
other	NULL
NFkB	NULL
inducers	NULL
suggest	NULL
the	NULL
existence	NULL
of	NULL
alternative	NULL
mechanisms	NULL
leading	NULL
to	NULL
IxB	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
.	NULL

Future	NULL
experiments	NULL
will	NULL
focus	NULL
on	NULL
the	NULL
identification	NULL
of	NULL
upstream	NULL
signaling	NULL
molecules	NULL
utilizing	NULL
reporter	NULL
gene	NULL
constructs	NULL
and	NULL
constitutively	NULL
activated	NULL
and	NULL
dominant	NULL
negative	NULL
signaling	NULL
mole-cules	NULL
.	NULL

ACKNOWLEDGEMENTS	NULL
This	NULL
work	NULL
was	NULL
done	NULL
during	NULL
the	NULL
tenure	NULL
of	NULL
an	NULL
Established	NULL
Investigatorship	NULL
(	NULL
to	NULL
R.D.Y	NULL
.	NULL
)	NULL

from	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
,	NULL
and	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
NIH	NULL
grants	NULL
GM46572	NULL
and	NULL
AI33503	NULL
.	NULL

This	NULL
is	NULL
publication	NULL
9768-IMM	NULL
from	NULL
the	NULL
Scripps	NULL
Research	NULL
Institute	NULL
.	NULL

Figures	NULL
2	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
10	NULL
were	NULL
reproduced	NULL
from	NULL
Pan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
and	NULL
Kravchenko	NULL
et	NULL
al	NULL
.	NULL

(	NULL
15	NULL
)	NULL
with	NULL
permission	NULL
from	NULL
The	NULL
Journal	NULL
of	NULL
Biological	NULL
Chemistry	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Avodonin	NULL
,	NULL
P.	NULL
V.	NULL
;	NULL
Svitina-Ulitina	NULL
,	NULL
I.	NULL
V.	NULL
;	NULL
Kulikov	NULL
,	NULL
V.	NULL
I.	NULL
Stimulation	NULL
of	NULL
high-affinity	NULL
hormone-sensitive	NULL
GTPase	NULL
of	NULL
human	NULL
platelets	NULL
by	NULL
platelet	NULL
activating	NULL
factor	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

131:307-313	NULL
;	NULL
1985	NULL
.	NULL

2	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
;	NULL
Henkel	NULL
,	NULL
T.	NULL
Function	NULL
and	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

32:141-179	NULL
;	NULL
1994	NULL
.	NULL

3	NULL
.	NULL

Baggiolini	NULL
,	NULL
M.	NULL
;	NULL
Dewald	NULL
,	NULL
B.	NULL
;	NULL
Moser	NULL
,	NULL
B.	NULL
Interleukin-8	NULL
and	NULL
related	NULL
chemotactic	NULL
cytokines-CXC	NULL
and	NULL
CC	NULL
chemokines	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

55:97-179	NULL
;	NULL
1994	NULL
.	NULL

4	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
;	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
Activation	NULL
of	NULL
multiple	NULL
NF-kappa	NULL
B/Rel	NULL
DNA-binding	NULL
complexes	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

Oncogene	NULL
9	NULL
:	NULL
1487-1492	NULL
;	NULL
1994	NULL
.	NULL

5	NULL
.	NULL

Cassatella	NULL
,	NULL
M.	NULL
A.	NULL
;	NULL
Bazzoni	NULL
,	NULL
F.	NULL
;	NULL
Ceska	NULL
,	NULL
M.	NULL
;	NULL
Ferro	NULL
,	NULL
I.	NULL
;	NULL
Baggiolini	NULL
,	NULL
M.	NULL
;	NULL
Berton	NULL
,	NULL
G.	NULL
IL-8	NULL
production	NULL
by	NULL
human	NULL
polymorphonuclear	NULL
leukocytes	NULL
:	NULL
The	NULL
chemoattractant	NULL
formyl-methionyl-leucyl-phenylalanine	NULL
induces	NULL
the	NULL
gene	NULL
expression	NULL
and	NULL
release	NULL
of	NULL
IL-8	NULL
through	NULL
a	NULL
pertussis	NULL
toxin-sensitive	NULL
pathway	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:3216-3220	NULL
;	NULL
1992	NULL
.	NULL

6	NULL
.	NULL

Chiao	NULL
,	NULL
P.	NULL
J.	NULL
;	NULL
Miyamoto	NULL
,	NULL
S.	NULL
;	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
Autoreg-ulation	NULL
of	NULL
IkBa	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:28-32	NULL
;	NULL
1994	NULL
.	NULL

7	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
;	NULL
Sacchi	NULL
,	NULL
N.	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
:	NULL
156-159	NULL
;	NULL
1987	NULL
.	NULL

214	NULL
8	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

Cogswell	NULL
,	NULL
J.	NULL
P.	NULL
;	NULL
Godlevski	NULL
,	NULL
M.	NULL
M.	NULL
;	NULL
Wisely	NULL
,	NULL
G.	NULL
B.	NULL
;	NULL
Clay	NULL
,	NULL
W.	NULL
C.	NULL
;	NULL
Leesnitzer	NULL
,	NULL
L.	NULL
M.	NULL
;	NULL
Ways	NULL
,	NULL
J.	NULL
P.	NULL
;	NULL
Gray	NULL
,	NULL
J.	NULL
G.	NULL
NF-kappa	NULL
B	NULL
regulates	NULL
IL-1	NULL
beta	NULL
transcription	NULL
through	NULL
a	NULL
consensus	NULL
NF-kappa	NULL
B	NULL
binding	NULL
site	NULL
and	NULL
a	NULL
nonconsensus	NULL
CRE-like	NULL
site	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:712-723	NULL
;	NULL
1994.	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
;	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
;	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
Ac	NULL
curate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nu-clei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
;	NULL
1983	NULL
.	NULL

Ember	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
;	NULL
Sanderson	NULL
,	NULL
S.	NULL
D.	NULL
;	NULL
Hugli	NULL
,	NULL
T.	NULL
E.	NULL
;	NULL
Mor-gan	NULL
,	NULL
E.	NULL
L.	NULL
Induction	NULL
of	NULL
interleukin-8	NULL
synthesis	NULL
from	NULL
monocytes	NULL
by	NULL
human	NULL
CSa	NULL
anaphylatoxin	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

144:393-403	NULL
;	NULL
1994	NULL
.	NULL

Fen	NULL
,	NULL
Z.	NULL
;	NULL
Dhadly	NULL
,	NULL
M.	NULL
S.	NULL
;	NULL
Yoshizumi	NULL
,	NULL
M.	NULL
;	NULL
Hilkert	NULL
,	NULL
R.	NULL
J.	NULL
;	NULL
Quertermous	NULL
,	NULL
T.	NULL
;	NULL
Eddy	NULL
,	NULL
R.	NULL
L.	NULL
;	NULL
Shows	NULL
,	NULL
T.	NULL
B.	NULL
;	NULL
Lee	NULL
,	NULL
M.-E	NULL
.	NULL

Structural	NULL
organization	NULL
and	NULL
chromo-somal	NULL
assignment	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
human	NULL
heparin-binding	NULL
-	NULL
epidermal	NULL
-	NULL
growth	NULL
-	NULL
factor-like	NULL
growth	NULL
factor/diptheria	NULL
toxin	NULL
receptor	NULL
.	NULL

Biochemistry	NULL
32:7932-7938	NULL
;	NULL
1993	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
S.	NULL
;	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
Mechanistic	NULL
aspects	NULL
of	NULL
NF-kappa	NULL
B	NULL
regulation	NULL
:	NULL
The	NULL
emerging	NULL
role	NULL
of	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
.	NULL

Immunity	NULL
3:263-272	NULL
;	NULL
1995	NULL
.	NULL

Goodman	NULL
,	NULL
M.	NULL
G.	NULL
;	NULL
Chenoweth	NULL
,	NULL
D.	NULL
E.	NULL
;	NULL
Weigle	NULL
,	NULL
W.	NULL
O	NULL
.	NULL

Induction	NULL
of	NULL
interleukin	NULL
1	NULL
secretion	NULL
and	NULL
enhancement	NULL
of	NULL
humoral	NULL
immunity	NULL
by	NULL
binding	NULL
of	NULL
human	NULL
CSa	NULL
to	NULL
macrophage	NULL
surface	NULL
CSa	NULL
receptors	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

1156:912-917	NULL
;	NULL
1982	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
The	NULL
regulation	NULL
of	NULL
AP-1	NULL
activity	NULL
by	NULL
mito-gen-activated	NULL
protein	NULL
kinases	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
16483-16486	NULL
;	NULL
1995	NULL
.	NULL

Kravchenko	NULL
,	NULL
V.	NULL
V.	NULL
;	NULL
Pan	NULL
,	NULL
Z.	NULL
;	NULL
Han	NULL
,	NULL
J.	NULL
;	NULL
Herbert	NULL
,	NULL
J.-M.	NULL
;	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
;	NULL
Ye	NULL
,	NULL
R.	NULL
D.	NULL
Platelet-activating	NULL
factor	NULL
induces	NULL
NF-kappa	NULL
$	NULL
activation	NULL
through	NULL
a	NULL
G	NULL
protein-coupled	NULL
pathway	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
14928-14934	NULL
;	NULL
1995	NULL
.	NULL

Liou	NULL
,	NULL
H.	NULL
C.	NULL
;	NULL
Baltimore	NULL
,	NULL
D.	NULL
Regulation	NULL
of	NULL
the	NULL
NF-kB/rel	NULL
transcription	NULL
factor	NULL
and	NULL
IkB	NULL
inhibitor	NULL
system	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

5:477-487	NULL
;	NULL
1993	NULL
.	NULL

Mari	NULL
,	NULL
B.	NULL
;	NULL
Imbert	NULL
,	NULL
V.	NULL
;	NULL
Belhacene	NULL
,	NULL
N.	NULL
;	NULL
Far	NULL
,	NULL
D.	NULL
F.	NULL
;	NULL
Peyron	NULL
,	NULL
J.	NULL
F.	NULL
;	NULL
Pouyssegur	NULL
,	NULL
J.	NULL
;	NULL
Van	NULL
Obberghen	NULL
Schilling	NULL
,	NULL
E.	NULL
;	NULL
Rossi	NULL
,	NULL
B.	NULL
;	NULL
Auberger	NULL
,	NULL
P.	NULL
Thrombin	NULL
and	NULL
thrombin	NULL
receptor	NULL
agonist	NULL
peptide	NULL
induce	NULL
early	NULL
events	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
synergize	NULL
with	NULL
TCR	NULL
cross-linking	NULL
for	NULL
CD69	NULL
expression	NULL
and	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:8517-8523	NULL
;	NULL
1994	NULL
.	NULL

Mukaida	NULL
,	NULL
N.	NULL
;	NULL
Okamoto	NULL
,	NULL
S.	NULL
;	NULL
Ishikawa	NULL
,	NULL
Y.	NULL
;	NULL
Matsushima	NULL
,	NULL
K.	NULL
Molecular	NULL
mechanism	NULL
of	NULL
interleukin-8	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

56:554-558	NULL
;	NULL
1994	NULL
.	NULL

Murphy	NULL
,	NULL
P.	NULL
M.	NULL
The	NULL
molecular	NULL
biology	NULL
of	NULL
leukocyte	NULL
chemoattractant	NULL
receptors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:593-633	NULL
;	NULL
1994	NULL
.	NULL

Nakano	NULL
,	NULL
T.	NULL
;	NULL
Raines	NULL
,	NULL
E.	NULL
W.	NULL
;	NULL
Abraham	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
;	NULL
Klags-brun	NULL
,	NULL
M.	NULL
;	NULL
Ross	NULL
,	NULL
R.	NULL
Lysophosphatidylcholine	NULL
upreg-ulates	NULL
the	NULL
level	NULL
of	NULL
heparin-binding	NULL
epidermal	NULL
growth	NULL
factor-like	NULL
growth	NULL
factor	NULL
mRNA	NULL
in	NULL
human	NULL
mono	NULL
21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

YE	NULL
ET	NULL
AL	NULL
.	NULL

cytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:1069-1073	NULL
;	NULL
1994	NULL
.	NULL

Oeth	NULL
,	NULL
P.	NULL
A.	NULL
;	NULL
Parry	NULL
,	NULL
G.	NULL
C.	NULL
;	NULL
Kunsch	NULL
,	NULL
C.	NULL
;	NULL
Nantermet	NULL
,	NULL
P.	NULL
;	NULL
Rosen	NULL
,	NULL
C.	NULL
A.	NULL
;	NULL
Mackman	NULL
,	NULL
N.	NULL
Lipopolysaccharide	NULL
induction	NULL
of	NULL
tissue	NULL
factor	NULL
gene	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
binding	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
to	NULL
a	NULL
kappa	NULL
B-like	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3772-3781	NULL
;	NULL
1994	NULL
.	NULL

Oppenheim	NULL
,	NULL
J.	NULL
J.	NULL
;	NULL
Zachariae	NULL
,	NULL
C.	NULL
O.	NULL
C.	NULL
;	NULL
Mukaida	NULL
,	NULL
N.	NULL
;	NULL
Matsushima	NULL
,	NULL
K.	NULL
Properties	NULL
of	NULL
the	NULL
novel	NULL
proinflammatory	NULL
supergene	NULL
``	NULL
intercrine	NULL
``	NULL
cytokine	NULL
family	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9:617-648	NULL
;	NULL
1991	NULL
.	NULL

Pan	NULL
,	NULL
Z.	NULL
;	NULL
Kravchenko	NULL
,	NULL
V.	NULL
V.	NULL
;	NULL
Ye	NULL
,	NULL
R.	NULL
D.	NULL
Platelet-activating	NULL
factor	NULL
stimulates	NULL
transcription	NULL
of	NULL
the	NULL
heparin-binding	NULL
epidermal	NULL
growth	NULL
factor-like	NULL
growth	NULL
factor	NULL
in	NULL
monocyte	NULL
.	NULL

Correlation	NULL
with	NULL
an	NULL
increased	NULL
kappa	NULL
B	NULL
binding	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
270:7787-7790	NULL
;	NULL
1995.	NULL
.	NULL

Prescott	NULL
,	NULL
S.	NULL
M.	NULL
;	NULL
Zimmerman	NULL
,	NULL
G.	NULL
A.	NULL
;	NULL
McIntyre	NULL
,	NULL
T.	NULL
M.	NULL
Human	NULL
endothelial	NULL
cells	NULL
in	NULL
culture	NULL
produce	NULL
platelet-activating	NULL
factor	NULL
(	NULL
I-alkyl-2-acetyl-sn-glycero-3-phos-phocholine	NULL
)	NULL
when	NULL
stimulated	NULL
by	NULL
thrombin	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
§1:3534-3538	NULL
;	NULL
1984	NULL
.	NULL

Ramirez	NULL
,	NULL
M.	NULL
T.	NULL
;	NULL
Post	NULL
,	NULL
G.	NULL
R.	NULL
;	NULL
Sulakhe	NULL
,	NULL
P.	NULL
V.	NULL
;	NULL
Brown	NULL
,	NULL
J.	NULL
H.	NULL
M1	NULL
muscarinic	NULL
receptors	NULL
heterolo-gously	NULL
expressed	NULL
in	NULL
cardiac	NULL
myocytes	NULL
mediate	NULL
Ras-dependent	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:8446-8451	NULL
;	NULL
1995	NULL
.	NULL

Ross	NULL
,	NULL
R.	NULL
The	NULL
pathogenesis	NULL
of	NULL
atherosclerosis	NULL
:	NULL
A	NULL
perspective	NULL
for	NULL
the	NULL
1990s	NULL
.	NULL

Nature	NULL
362:801-809	NULL
;	NULL
1993	NULL
.	NULL

Schindler	NULL
,	NULL
R.	NULL
;	NULL
Gelfand	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
;	NULL
Dinarello	NULL
,	NULL
C.	NULL
A.	NULL
Re-combinant	NULL
CSa	NULL
stimulates	NULL
transcription	NULL
rather	NULL
than	NULL
translation	NULL
of	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
:	NULL
Translational	NULL
signal	NULL
provided	NULL
by	NULL
lipopolysaccharide	NULL
or	NULL
IL-1	NULL
itself	NULL
.	NULL

Blood	NULL
76:1631-1638	NULL
;	NULL
1990	NULL
.	NULL

Schlondorff	NULL
,	NULL
D.	NULL
;	NULL
Singhal	NULL
,	NULL
P.	NULL
;	NULL
Hassid	NULL
,	NULL
A.	NULL
;	NULL
Satriano	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
;	NULL
DeCandido	NULL
,	NULL
S.	NULL
Relationship	NULL
of	NULL
GTP-binding	NULL
proteins	NULL
,	NULL
phospholipase	NULL
C	NULL
,	NULL
and	NULL
PGE2	NULL
synthesis	NULL
in	NULL
rat	NULL
glomerular	NULL
mesangial	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

256	NULL
:	NULL
F171-F178	NULL
;	NULL
1989	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
;	NULL
Baltimore	NULL
,	NULL
D.	NULL
Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
se-quences	NULL
.	NULL

Cell	NULL
46:705-716	NULL
;	NULL
1986	NULL
.	NULL

Snyderman	NULL
,	NULL
R.	NULL
;	NULL
Uhing	NULL
,	NULL
R.	NULL
J.	NULL
Phagocytic	NULL
cells	NULL
:	NULL
Stim-ulus-response	NULL
coupling	NULL
mechanisms	NULL
.	NULL

In	NULL
:	NULL
Gallin	NULL
,	NULL
J.	NULL
I.	NULL
;	NULL
Goldstein	NULL
,	NULL
I.	NULL
M.	NULL
;	NULL
Snyderman	NULL
,	NULL
R.	NULL
,	NULL
eds	NULL
.	NULL

Inflamma-tion	NULL
:	NULL
Basic	NULL
principles	NULL
and	NULL
clinical	NULL
correlates	NULL
.	NULL

2nd	NULL
ed	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Raven	NULL
Press	NULL
;	NULL
1992:421-439	NULL
.	NULL

Springer	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

Traffic	NULL
signals	NULL
for	NULL
lymphocyte	NULL
recir-culation	NULL
and	NULL
leukocyte	NULL
emigration	NULL
:	NULL
The	NULL
multistep	NULL
paradigm	NULL
.	NULL

Cell	NULL
76:301-314	NULL
;	NULL
1994	NULL
.	NULL

Strieter	NULL
,	NULL
R.	NULL
M.	NULL
;	NULL
Kasahara	NULL
,	NULL
K.	NULL
;	NULL
Allen	NULL
,	NULL
R.	NULL
M.	NULL
;	NULL
Standi-ford	NULL
,	NULL
T.	NULL
J.	NULL
;	NULL
Rolfe	NULL
,	NULL
M.	NULL
W.	NULL
;	NULL
Becker	NULL
,	NULL
F.	NULL
S.	NULL
;	NULL
Chensue	NULL
,	NULL
S.	NULL
W.	NULL
;	NULL
Kunkel	NULL
,	NULL
S.	NULL
L.	NULL
Cytokine-induced	NULL
neutrophils-derived	NULL
interleukin-8	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

141:397-407	NULL
;	NULL
1992	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
C.	NULL
;	NULL
Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
;	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
;	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
NF-kB	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IkKB	NULL
:	NULL
CHEMOATTRACTANT-INDUCED	NULL
GENE	NULL
EXPRESSION	NULL
215	NULL
Evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
;	NULL
1993	NULL
.	NULL

34	NULL
.	NULL

Van	NULL
Obberghen	NULL
Schilling	NULL
,	NULL
E.	NULL
;	NULL
Pouyssegur	NULL
,	NULL
J	NULL
.	NULL

Signaling	NULL
pathways	NULL
of	NULL
the	NULL
thrombin	NULL
receptor	NULL
.	NULL

Thromb	NULL
.	NULL

Haemost	NULL
.	NULL

70:163-167	NULL
;	NULL
1993	NULL
.	NULL

35	NULL
.	NULL

Whatley	NULL
,	NULL
R.	NULL
E.	NULL
;	NULL
Zimmerman	NULL
,	NULL
G.	NULL
A.	NULL
;	NULL
McIntyre	NULL
,	NULL
T.	NULL
M.	NULL
Endothelium	NULL
from	NULL
diverse	NULL
vascoular	NULL
sources	NULL
36.	NULL
synthesizes	NULL
platelet-activating	NULL
factor	NULL
.	NULL

Arteriosclerosis	NULL
8:321-331	NULL
;	NULL
1988	NULL
.	NULL

Zimmerman	NULL
,	NULL
G.	NULL
A.	NULL
;	NULL
McIntyre	NULL
,	NULL
T.	NULL
M.	NULL
;	NULL
Mehra	NULL
,	NULL
M.	NULL
;	NULL
Prescott	NULL
,	NULL
S.	NULL
M.	NULL
Endothelial	NULL
cell-associated	NULL
platelet-activating	NULL
factor	NULL
:	NULL
A	NULL
novel	NULL
mechanism	NULL
for	NULL
signaling	NULL
intercellular	NULL
adhesion	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

110:529-540	NULL
;	NULL
1990	NULL
.	NULL

